ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

House Passes Bill Authorizing NIH Funds; Veto Likely

August 2, 1991

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002